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Introduction  
An alternative to traditional treatment modalities for diabetic ulcers is low-level laser therapy 
(LLLT). A number of published studies demonstrate the beneficial effects of LLLT (Ribeiro et al, 
2002), although several other studies also exist which indicate results to the contrary (Malm and 
Lundeberg, 1991; Loevschall and Arenholt-Bindslev, 1994). Further work focusing on cellular and 
molecular mechanisms of responses to laser irradiation is required to establish LLLT as a 
reliable, safe and inexpensive treatment modality. This article reviews LLLT as a treatment 
modality for diabetic ulcers.  
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Due to its serious complications diabetes remains an important cause of morbidity and mortality. 
The principal complications arise from macro- and microangiopathy. The nervous system is also 
affected, which can lead to sensory loss and subsequent damage to the limbs. Atrophy of fat and 
muscle tissue, combined with sensory loss, can result in pressure sores on the feet, which, in 
turn, can lead to lower-limb amputation. Approximately 15% of people with diabetes will develop 
foot ulcers, and 6% of these will require hospitalization for the treatment of such ulcers 
(Carrington et al, 2001). Diabetes accounts for 50% of all non-traumatic amputations (Schindl et 
al, 1998). Changes to the vascular system results in delayed wound healing. People with 
diabetes have poor circulation, poor resistance to infection, and poor local nutrition, thus these 
wounds are highly susceptible to infection.  
Low-level laser therapy  
Low-level laser therapy (LLLT; also known as biostimulation and photobiostimulation) is a form of 
phototherapy that involves the application of low-power monochromatic and coherent light to 
injuries and lesions in order to stimulate wound healing. LLLT has been shown to increase the 
speed, quality and tensile strength of tissue repair, resolve inflammation and provide pain relief 
(supporting literature is reviewed later in the article). Lasers are already used in a variety of 
medical and surgical fields, including dentistry, chiropractice, osteopathy, physiotherapy, 
cosmetic, pain attenuation, wound healing and acupuncture to name but a few (e.g. Walsh, 
1997).  
The effects of LLLT are photochemical, not thermal, and the responses of cells occur due to 
changes in photoacceptor molecules (also known as chromophores [molecules which are able to 
absorb photonic energy]; Tuner and Hode, 2002), such as porphyrin. The exact mechanism of 
action of LLLT is not completely understood. However, it is known that during laser irradiation 
cells absorb photonic energy that is incorporated into chromophores, which, in turn, stimulates 
cellular metabolism (Pinheiro et al, 2002).  
The chromophore is able to transfer the absorbed energy to other molecules and thus cause 
chemical reactions in surrounding tissue. The acceptor molecules' kinetic energy is increased, 
thereby activating or deactivating enzymes, which, in turn, are able to alter the physical and/or 
chemical properties of other macromolecules (for example DNA and RNA; Matic et al, 2003; 
Takac and Stojanovic, 1998) in order to facilitate wound healing. Energy which is delivered to the 
cells produces insignificant and minimal temperature changes, typically in the range of 0.1-
0.5[degrees]C (Nemeth, 1993).  
LLLT and wound healing  
Normal wound healing requires both destructive and reparative processes in controlled balance. 
Proteases and growth factors play an important role in regulating this balance, and if disrupted in 
favour of degradation then delayed healing ensues, which is a trait of chronic wounds (Cullen et 
al, 2002). It has been shown that low-level laser irradiation at certain fluences and wavelengths 
can enhance the release of growth factors and stimulate cell proliferation (Yu et al, 2001).  
The effects of LLLT include wound epithelialisation, reduction of oedema and inflammation, and 
re-establishment of arterial, venous and lymph microcirculation. Increased rates of ATP, RNA and 
DNA synthesis are also observed (Takac and Stojanovic, 1998). Major changes seen in wounds 
treated with LLLT include increased granulation tissue, early epithelialisation, increased fibroblast 
proliferation, increased extracellular matrix synthesis and enhanced neovascularisation (Walsh, 
1997), all of which lead to better tissue oxygenation and nutrition, and, in turn, enhanced wound 
healing. The effects of LLLT on wound healing are summarised in Table 1.  
It has been shown that low-level irradiation of fibroblasts stimulates the production of basic 
fibroblast growth factor and stimulates the transformation of fibroblasts into myofibroblasts 
(Walsh, 1997). LLLT also affects immune cells, and acts directly and selectively on the immune 
system (Tadakuma, 1993). Stimulation of the immune system means that infected wounds can be 
cleared more readily. The use of low-level lasers in wound healing has been shown to speed up 
the healing of leg ulcers and burn wounds; it has also been shown to improve skin-healing 
capabilities (Ribeiro et al, 2002).  
LLLT and wound healing in vitro  
It has been shown that exposure to a 308nm excimer laser reduces bacterial growth in vitro 
(Folwaczny et al, 1998). This may be of significant clinical importance in bacterially infected 
wounds: not only could LLLT increase wound closure, but it may also speed up the clearing of an 
infected wound--a definite benefit to people with diabetes.  
LLLT and diabetic wound healing in rodents  
Yu and colleagues (1997) evaluated whether low-level laser irradiation could improve wound 
healing in mice with diabetes. Genetically diabetic mice (C57BL/KsJ-db/db) were exposed to an 
argon dye laser (wavelength: 630nm; power density: 20mW/[cm.sup.2] [see Table 2 for 
definitions]). They demonstrated that laser irradiation enhanced wound closure over time; 
histological evaluation indicated improved wound epithelialisation, cellular content, granulation 
tissue formation and collagen deposition as compared to the negative control group.  
LLLT has also been shown to enhance cutaneous wound tensile strength. Stadler and colleagues 
(2001) exposed the wounds of wounded female C57BL/KsJ-db/db mice to low-level laser 
irradiation and measured tensile strength. The wounded mice were exposed to low-level laser 
irradiation daily for 5 days, (wavelength: 830nm; power density: 79mW/[cm.sup.2]; energy 
density: 5.0J/[cm.sup.2] [see Table 2 for definitions]) starting either on the day of wounding or 3 
days later. Compared with control mice (which received no irradiation) there was an increase in 
tensile strength in exposed mice sacrificed on days 11 and 23 post-injury. Higher tensile 
strengths were noted at 23 days in mice that received their course of irradiation 3 days after 
wounding. Stadler and colleagues (2001) felt that further investigation of the mechanism of LLLT 
in primary wound healing is warranted.  
Reddy and colleagues (2001) concluded that photobiostimulation promotes tissue repair by 
accelerating the production of collagen and promotes overall connective tissue stability in wound 
healing. Male rats with streptozotocin-induced diabetes received circular wounds 6mm in 
diameter either side of the spine--one wound was treated with a helium--neon (He--Ne) laser 
(wavelength: 632.8nm; energy density: 1.0J/[cm.sup.2]) 5 days per week until there was wound 
closure. The other wound received no laser irradiations and was used as the control. In 2003, 
Reddy compared these results with wounded rats with streptozotocin-induced diabetes exposed 
to a gallium--arsenide (Ga--As) laser (wavelength: 904nm; energy density: 1.0J/[cm.sup.2]). The 
wound to the left of the spine was irradiated 5 days per week for a period of 3 weeks, while the 
wound to the right was used as a control. After 3 weeks, the rats were sacrificed and the wound 
sites analysed (Reddy, 2003). Measurements of the He--Ne-irradiated wounds indicated there 
was an increase in maximum load, stress, strain, energy absorption and toughness compared 
with the controls (Reddy et al, 2001). There was an increase in tensile strength and toughness of 
the wound exposed to the Ga--As laser as compared with the control wounds. There were no 
changes in energy absorption between the control and irradiated wounds (Reddy, 2003).  
Biochemical analysis revealed that the amount of total collagen was significantly increased in 
laser-treated wounds over control wounds, with an increase in the concentration of acid- and salt-
soluble collagen and insoluble collagen. There was also a decrease in proteolytic digestion as 
measured by a decrease in pepsin-soluble collagen (Reddy et al, 2001; Reddy, 2003). It is the 
opinion of Reddy (2003) that irradiation with an He--Ne laser for wound healing in mice with 
diabetes is better than irradiation with a Ga--As laser, and that the different biochemical 
responses may be wavelength and coherence dependent.  
LLLT and diabetic wound healing in humans  
Exposure to low-level laser irradiation abates the inflammatory reaction and stimulates the 
immune system, leading to an increase in wound healing in infected wounds in people with 
diabetes (Khurshudian, 1989). Khurshudian treated 174 people with diabetes with suppurative 
diseases. Patients were exposed to a helium--cadmium laser beam of wavelength 441.6nm. A 
single exposure to 4.5J/[cm.sup.2] led to a rapid decrease in the inflammatory reaction, and there 
was a cleansing and acceleration of regeneration processes in the infected wounds.  
This was supported by work conducted by Kuliev and Babaev (1991). They studied the immune 
status after laser irradiation in 152 people with diabetes with purulent soft tissue injuries. There 
was a rapid stabilisation of the immune system, thus reducing the duration of treatment. Potinen 
(1992) determined the stabilisation of the immune system by the observation of the increased 
release of various cytokines upon LLLT. He also observed an increase in the leucocyte 
population and an arrest in bacterial growth.  
Kuliev and colleagues (1992) determined the effectiveness of including both a magnetic field 
(provided by various methods such as magnetic bracelets and wraps) and LLLT in the treatment 
of 119 people with diabetes with suppurative wounds. Immunological status was stabilised in a 
shorter time and the process of wound healing followed a quicker course, resulting in a shortened 
treatment time. It was suggested that the magnetic-laser combined effect has an advantage over 
the separate use of these factors.  
Low-level laser irradiation induces wound healing in conditions of reduced microcirculation. 
Schindl and colleagues investigated the effect of LLLT in patients with diabetic microangiopathy 
by infrared thermography on skin blood circulation (Schindl et al, 1998; Schindl et al, 2002). In the 
first study (Schindl et al, 1998), 30 people with diabetic ulcers or gangrene received either a 
single low-intensity laser irradiation (He--Ne laser; wavelength: 632.8nm; beam power: 30m/W; 
energy density: 30J/[cm.sup.2]), or a sham irradiation over both forefoot regions. At 20 minutes of 
laser irradiation, there was a significant rise in skin temperature in the forefoot area, with an 
increase of 0.58 [+ or -] 0.68[degrees]C (P<0.001). The increase was 1.06 [+ or -] 1.03[degrees]C 
at the end of irradiation (50 minutes; P<0.001) and 1.22 [+ or -] 1.01[degrees]C (P<0.001) 15 
minutes after the end of irradiation. There was a slight, but significant, drop in skin temperature in 
the placebo group (P<0.001).  
In the second study (Schindl et al, 2002), patients were exposed once to an He--Ne laser, 
(wavelength: 632.8nm; energy density: 30J/[cm.sup.2]), or a sham irradiation over the forefoot 
region of one foot. A rise in skin temperature in both feet in the laser group was noted, whereas a 
drop in both feet in the placebo group was noted. The group showed that athermic laser 
irradiation on one foot in people with diabetes with angiopathy causes a significant increase in 
skin circulation in both feet and points to the possibility of systemic effects.  
Schindl and colleagues (Schindl et al, 1999) conducted a study on a person with diabetes with 
sensory neuropathy, macroangiopathy and microangiopathy. The patient was exposed (in 16 
sessions within a 4-week period) to a 670nm diode laser, as well as conventional treatments 
(such as using dressings and antibiotics). There was complete healing of the ulcer with no 
recurrence after 9 months, despite the patient's unstable metabolic condition. Despite the fact 
that LLLT was not applied alone, LLLT may be a useful alternative treatment modality for the 
induction of wound healing of ulcers in people with diabetes which is free of side effects.  
Exposure of blood to LLLT results in a decrease in free radical oxidation (Grigor'eva et al, 1991). 
Grigor'eva and colleagues investigated the activity of primary and secondary products of lipid 
peroxidation and antiperoxide protection enzymes. The blood of 33 people with diabetes was 
irradiated for 60 minutes with the help of a light guide. After laser irradiation, there was a 
decrease in the activity of processes of free radical oxidation compared with blood samples taken 
before laser irradiations. This decrease is probably due to the effect of LLLT on antiperoxide 
enzymes. The group also found an increase in microcirculation, which is in accordance with the 
work of Schindl and colleagues (Schindl et al, 1998; 2002).  
Current literature  
Currently there is no accepted theory to explain the mechanism of low-level laser biostimulation, 
and this lack of knowledge complicates the evaluation of conflicting reports in the literature. 
Lasers have been shown to be both stimulatory and inhibitory. These differences in the literature 
can be explained by the different treatment parameters used, such as wavelength, fluence, output 
power and treatment regimens (Baxter et al, 1991). Few articles provide all the relevant laser 
parameters, making it difficult to reproduce the work. Patient status, size and type of wound also 
play important roles. LLLT has been used extensively in former Eastern bloc countries, thus there 
is a vast amount of experience and information available, although most of this work is published 
in Russian journals, and during the translation of these papers information can become lost.  
According to the American Diabetes Association (1999), the following criteria should be included 
when evaluating new treatments for diabetic foot wound care: randomised controlled studies; a 
sufficient number of patients; relevant outcomes; control patients; primary end point, with a 
proportion of patients with complete wound healing within the study period; and evaluation of the 
cost and effectiveness of the treatment and the quality of the patient's life. Of all the studies 
mentioned in this paper, none of them make mention of the costs and quality of patient life. The 
paper by Schindl and colleagues (1999) was written on a single patient.  
Conclusion  
The exploitation of phototherapy in medicine and surgery is of great interest, and there is a 
growing interest in the use of lasers for the treatment of various conditions and disorders, 
including the treatment of diabetic wounds. There is a need to develop alternative treatment 
modalities which can improve the endogenous capacity of the healing process, particularly during 
disease conditions with impaired wound healing. Using lasers as a source of photobiostimulation 
looks to be an attractive branch of medicine for the future.  
Chronic skin ulcers present a challenge in dermatology, and among the various non-invasive 
treatments used in wound healing, LLLT has steadily increased in its applications to include a 
wide variety of medical and surgical specialties (such as physiotherapists, dentists, 
dermatologists and rheumatologists, and also in nerve regeneration; Karu, 2003). LLLT as a 
treatment is a choice that appeals to people (Forney and Mauro, 1999), it is a simple and non-
invasive treatment that offers pain relief and has no reported side effects. As outlined above, 
LLLT has been shown by various studies to be effective in the treatment of diabetic wound 
healing.  
Due to disturbances of the circulation in people with diabetes, wounds heal slowly and are 
susceptible to infection. LLLT has been shown to speed up the time needed for wound closure in 
people with diabetes (Khurshudian, 1989; Kuliev and Babaev, 1991; Yu et al, 1997; Reddy et al, 
2001); and there is improved wound epithelialisation, increased cellular content, increased 
granulation tissue formation and increased collagen deposition (Yu et al, 1997). There is a 
decrease in the inflammatory reaction (Khurshudian, 1989), and a stimulatory effect on the 
immune system (Khurshudian, 1989; Kuliev and Babaev, 1991). LLLT has also been shown to 
increase microcirculation (Grigor'eva et al, 1991; Schindl et al, 1998; Schindl et al, 1999; Schindl 
et al, 2002), enhance wound tensile strength (Stadler et al, 2001), accelerate collagen production 
(Reddy et al, 2001; Reddy, 2003), and decrease free radical oxidation processes (Grigor'eva et 
al, 1991) in people with diabetes.  
Due to the increasing cost of care of diabetic wounds, and the burden incurred by the patients 
and society, there is a need to develop new, inexpensive and safe treatment modalities which 
increase wound healing. From the results of published studies on diabetic wound healing, large, 
properly controlled studies seem justified. At the correct wavelength, intensity and fluence, LLLT 
can be a complementary therapy modality in the treatment of impaired wound healing and future 
research should be developed to find adequate wavelengths and doses.  
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RELATED ARTICLE: ARTICLE POINTS  
1 Low-level laser therapy (LLLT) is an alternative treatment modality for diabetic wounds.  
2 LLLT increases the speed, quality and tensile strength of tissue repair, and also resolves 
inflammation and provides pain relief.  
3 LLLT is a noninvasive treatment with no reported side effects.  
4 LLLT improves wound epithelialisation and increases cellular content, granulation tissue, 
collagen deposition and microcirculation.  
5 LLLT stimulates the immune system, enhances wound tensile strength and decreases free 
radical oxidation processes.  
RELATED ARTICLE: PAGE POINTS  
1 The use of low-level lasers in wound healing has been shown to speed up healing of leg ulcers 
and burn wounds; it has also been shown to improve skin-healing capabilities.  
2 It has been shown that exposure to a 308nm excimer laser reduces bacterial growth in vitro.  
RELATED ARTICLE: PAGE POINTS  
1 Low-level laser therapy has also been shown to enhance cutaneous wound tensile strength.  
2 Irradiation with an He--Ne laser for wound healing in mice with diabetes is better than irradiation 
with a Ga-As laser, and that the different biochemical responses may be wavelength and 
coherent dependent.  
RELATED ARTICLE: PAGE POINTS  
1 The magnetic-laser effect has an advantage over the separate use of these factors.  
2 Exposure of blood to LLLT has shown a decrease in free radical oxidation.  
3 LLLT as a treatment is a choice that appeals to people, it is a simple and non-invasive 
treatment that offers pain relief and has no reported side effects.  
4 Due to disturbances to circulation in people with diabetes, wounds heal slowly and are 
susceptible to infection.  
RELATED ARTICLE: PAGE POINTS  
1 Due to the increasing cost of care of diabetic wounds, and the burden incurred by the patients 
and society, there is a need to develop new, inexpensive and safe treatment modalities, which 
increase wound healing.  
  
Table 1. Summary of events during wound healing and the effects of  
low-level laser therapy (LLLT; adapted from Pearl and Kanat, 1988).  
  
Phase          Duration                     Events  
  
Lag            0-10 days                    Inflammation  
                                            Clot formation  
                                            Epithelialisation  
                                            Fibroblast migration  
Proliferation  2-4 weeks                    Mitogenesis  
                                            Fibrinogenesis  
                                            Cellular migration  
                                            Wound contraction  
                                            Angiogenesis  
                                            Granulation tissue 
formation  
                                            Epithelialisation  
Remoulding     [greater than or equal to]1  Scar formation  
                 year                       Collagen maturation  
                                            Collagen synthesis and 
lysis  
                                              in balance  
  
Phase          Effects of LLLT at all phases  
  
Lag            Increased epithelialisation  
               Re-establishment of arterial venous and lymph  
                 microcirculation  
               Decreased oedema  
               Pain attenuation  
               Increased ATP, RNA and DNA synthesis  
Proliferation  Increased granulation tissue  
               Increased mitogenesis  
               Increased neovascularisation  
               Increased matrix synthesis  
               Increased fibrinogenesis  
               Decreased inflammation  
               Increased cytokines and growth factors  
               Increased stimulation of immune system  
Remoulding     Increased tissue nutrition and oxygenation  
               Increased wound closure  
               Increased angiogenesis  
               Increased tensile strength  
  
Table 2. Explanation of units used for LLLT.  
  
Power density refers to the light output per unit area of the target  
tissue being irradiated. This is measured in watts per square 
centimetre  
(W/[cm.sup.2]) or milliwatts per square centimetre (mW/[cm.sup.2]).  
  
Energy density is equivalent to dose (or fluence) and is measured in  
joules per square centimetre (J/[cm.sup.2]). Energy density refers to  
the amount of energy per unit area brought to bear on the tissue being  
irradiated. It is measured using the following formula.  
  
Energy density (D;J/[cm.sup.2]) = [power (W; watts) X  
time (s; seconds)]/[area treated ([cm.sup.2])]  
  
The wavelength of the lasers used is always measured in nanometres 
(nm).  
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